Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Feb. 02, 2019	Feb. 03, 2018	Jan. 28, 2017
Cash flows from operating activities:
Net loss	$ (13,531)	$ (18,826)	$ (2,256)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of deferred gain on sale-leaseback	(1,465)	(1,465)	(1,466)
Amortization of deferred debt issuance costs	171	270	276
Write-off of deferred debt issuance costs	186
Impairment of assets	4,579	4,095	376
Depreciation and amortization	28,653	31,073	30,245
Deferred taxes, net of valuation allowance		(2,363)	26
Stock compensation expense	2,004	1,636	1,256
Issuance of common stock to Board of Directors	594	534	482
Changes in operating assets and liabilities:
Accounts receivable	(1,374)	4,068	(2,393)
Inventories	(3,505)	14,114	7,568
Prepaid expenses and other current assets	(464)	(1,110)	(563)
Other assets		60	(247)
Accounts payable	431	2,729	574
Deferred rent and lease incentives	(3,879)	297	4,487
Accrued expenses and other liabilities	3,341	(4,153)	(3,405)
Net cash provided by operating activities	15,741	30,959	34,960
Cash flows from investing activities:
Additions to property and equipment, net	(11,811)	(22,565)	(29,239)
Purchase of intangible asset	(1,150)
Net cash used for investing activities	(12,961)	(22,565)	(29,239)
Cash flows from financing activities:
Net borrowings (repayments) under credit facility	(5,334)	3,165	1,993
Proceeds from the issuance of long-term debt	15,000
Principal payments on long-term debt	(12,251)	(7,088)	(7,312)
Costs associated with debt issuances	(553)
Repurchase of common stock		(4,681)
Tax withholdings paid related to net share settlements of RSUs	(136)
Net cash used for financing activities	(3,274)	(8,604)	(5,319)
Net increase (decrease) in cash and cash equivalents	(494)	(210)	402
Cash and cash equivalents:
Beginning of period	5,362	5,572	5,170
End of period	$ 4,868	$ 5,362	$ 5,572